Trial intelligence / Profile preview

Intranasal Midazolam for Preanasthetic Sedation for Preschool Children Undergoing Adenotonsillectomy

NCT07045597Completed

Sponsor
Sohag University
Start
Mar 2025
Primary completion
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of midazolam in Adenotonsillar hypertrophy (ATH) (2 arms), sponsored by Sohag University. Primary endpoint: Sedative effect of preanesthetic Midazolam. Started Mar 2025; status: completed.

02

Drugs

midazolam
03

Conditions

Adenotonsillar hypertrophy (ATH)

Beyond the preview

Go deeper on NCT07045597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07045597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call